Related Experiment Video

Updated: May 30, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Clinical trials in triple negative breast cancer

Katherine E Reeder-Hayes1, Lisa A Carey, William M Sikov

  • 1Department of Hematology-Oncology, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.

Breast Disease
|July 23, 2011
PubMed

Insights

Triple negative breast cancer (TNBC) is aggressive, lacking effective targeted therapies. Research explores new treatments like platinum analogs and PARP inhibitors, showing promise for better patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology

Background:

  • Triple negative breast cancer (TNBC) is an aggressive subtype unresponsive to standard targeted therapies.
  • Effective treatments for TNBC remain a significant clinical challenge.

Purpose of the Study:

  • To summarize the current understanding of TNBC biology.
  • To review the efficacy of standard and investigational therapies for TNBC.

Main Methods:

  • Literature review of TNBC biology and therapeutic strategies.
  • Analysis of preliminary clinical trial data for novel agents.

Main Results:

  • Platinum analogs and PARP inhibitors show promising results in TNBC treatment.
  • Anti-angiogenic therapies and EGFR inhibitors have limited efficacy.
  • Agents targeting SRC and PI3K pathways are in early clinical trials.

Conclusions:

  • Further understanding of TNBC biology is crucial for treatment selection.
  • Tailoring therapies to specific patient subgroups can reduce disease burden.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...